| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $496K | — | -65.3% |
| Cost of Revenue | $245K | — | -75.9% |
| Gross Profit | $251K | — | -39.0% |
| R&D Expense | $10K | — | — |
| SG&A Expense | $2.6M | — | +194.2% |
| Operating Income | -$2.7M | — | -209.2% |
| Interest Expense | $6K | — | — |
| Net Income | -$3.7M | — | -306.2% |
| EPS (Basic) | -$0.21 | — | -162.5% |
| EPS (Diluted) | -$0.21 | — | -162.5% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $182K | -62.7% | -84.2% |
| Current Assets | $522K | -12.8% | -63.2% |
| Total Assets | $1.1M | -12.6% | -53.2% |
| Current Liabilities | $4.8M | +6.0% | +50.9% |
| Total Liabilities | $5.0M | -6.3% | +28.5% |
| Stockholders' Equity | -$3.9M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$291K | — | +42.1% |
| Financing Cash Flow | $565K | — | +1030.8% |
| -163.5% |